Why Russia wants to partner with India for producing vaccines?

On Thursday, Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF) said, “Russia is ready to have a partnership with India for producing COVID-19 vaccine Sputnik V.” Russian President Vladimir Putin had announced that his country has developed the world’s first vaccine against COVID-19. He explained that it is working “quite effectively” and forming a “stable immunity” against the disease.

Gamaleya Research Institute of Epidemiology and Microbiology had successfully developed SputnikV alongside RDIF. The vaccine has not been tested in Phase 3 or larger clinical trials.

In Online press briefing, Dmitriev said, “several nations are interested in the production of the vaccine from countries in Latin America, Asia, and the Middle East.”

He added, “The production of the vaccine is a very important issue. Currently, we are looking for a partnership with India. We believe that they are capable of producing the Gamaleya vaccine and it is very important to say that those partnerships to produce the vaccine will enable us to cover the demand that we have.”

Dmitriev said Russia is looking forward to having strong international cooperation, especially on manufacturing Coronavirus Vaccines as soon as possible to benefit the world and to end this Global Pandemic Crisis.

“We are going to do clinical trials not just in Russia but also in the UAE, Saudi Arabia, probably in Brazil and India. We are planning to produce the vaccine in more than five countries and there is a very high demand from Asia, Latin America, Italy, and other parts of the world regarding the delivery of the vaccine,” he said.

As of now from India already working on three vaccines discussed in the media briefing today.

Also Read: Coronavirus vaccine update: Russia may partner India for producing vaccines